company background image
MEPA

Medical PackagingCASE:MEPA Stock Report

Market Cap

ج.م140.8m

7D

-13.7%

1Y

9.7%

Updated

22 Oct, 2021

Data

Company Financials
MEPA fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance2/6
Financial Health3/6
Dividends0/6

MEPA Overview

Medical Packaging Company manufactures and sells glass packaging for pharmaceutical and medical purposes in Egypt and internationally.

Price History & Performance

Summary of all time highs, changes and price drops for Medical Packaging
Historical stock prices
Current Share Priceج.م0.41
52 Week Highج.م0.33
52 Week Lowج.م1.14
Beta0.56
1 Month Change-20.31%
3 Month Change-20.93%
1 Year Change9.68%
3 Year Change153.42%
5 Year Change187.32%
Change since IPO-65.48%

Recent News & Updates

Shareholder Returns

MEPAEG PackagingEG Market
7D-13.7%-0.7%-0.8%
1Y9.7%101.7%11.1%

Return vs Industry: MEPA underperformed the EG Packaging industry which returned 101.7% over the past year.

Return vs Market: MEPA underperformed the EG Market which returned 11.1% over the past year.

Price Volatility

Is MEPA's price volatile compared to industry and market?
MEPA volatility
MEPA Beta0.56
Industry Beta1.18
Market Beta1

Stable Share Price: MEPA is not significantly more volatile than the rest of EG stocks over the past 3 months, typically moving +/- 7% a week.

Volatility Over Time: MEPA's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2006n/aMahir Syedhttps://www.med-pack.com

Medical Packaging Company manufactures and sells glass packaging for pharmaceutical and medical purposes in Egypt and internationally. The company offers ampoule form A, B, C, and D; ampoule marzocchi; vial; and aluminum caps. It also provides one-point cut ampoules, ceramic printed ampoules, and other products in various designs, sizes, and colors, as well as various flat based and constricted neck ampoules, and flame cut ampoules for the packaging of pharmaceutical liquid products.

Medical Packaging Fundamentals Summary

How do Medical Packaging's earnings and revenue compare to its market cap?
MEPA fundamental statistics
Market Capج.م140.76m
Earnings (TTM)ج.م5.99m
Revenue (TTM)ج.م40.28m

23.5x

P/E Ratio

3.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
MEPA income statement (TTM)
Revenueج.م40.28m
Cost of Revenueج.م29.32m
Gross Profitج.م10.97m
Expensesج.م4.98m
Earningsج.م5.99m

Last Reported Earnings

Jun 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)0.017
Gross Margin27.23%
Net Profit Margin14.87%
Debt/Equity Ratio31.3%

How did MEPA perform over the long term?

See historical performance and comparison

Valuation

Is Medical Packaging undervalued compared to its fair value and its price relative to the market?

23.5x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: MEPA (EGP0.41) is trading above our estimate of fair value (EGP0.4)

Significantly Below Fair Value: MEPA is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: MEPA is poor value based on its PE Ratio (23.5x) compared to the African Packaging industry average (9.8x).

PE vs Market: MEPA is poor value based on its PE Ratio (23.5x) compared to the EG market (11.6x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate MEPA's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: MEPA is overvalued based on its PB Ratio (2x) compared to the XF Packaging industry average (1.3x).


Future Growth

How is Medical Packaging forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

18.7%

Forecasted Materials industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Medical Packaging has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has Medical Packaging performed over the past 5 years?

57.9%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: MEPA has high quality earnings.

Growing Profit Margin: MEPA's current net profit margins (14.9%) are lower than last year (16.8%).


Past Earnings Growth Analysis

Earnings Trend: MEPA has become profitable over the past 5 years, growing earnings by 57.9% per year.

Accelerating Growth: MEPA's earnings growth over the past year (2.4%) is below its 5-year average (57.9% per year).

Earnings vs Industry: MEPA earnings growth over the past year (2.4%) underperformed the Packaging industry 6.7%.


Return on Equity

High ROE: MEPA's Return on Equity (8.6%) is considered low.


Financial Health

How is Medical Packaging's financial position?


Financial Position Analysis

Short Term Liabilities: MEPA's short term assets (EGP31.5M) do not cover its short term liabilities (EGP35.5M).

Long Term Liabilities: MEPA's short term assets (EGP31.5M) exceed its long term liabilities (EGP4.5M).


Debt to Equity History and Analysis

Debt Level: MEPA's debt to equity ratio (31.3%) is considered satisfactory.

Reducing Debt: MEPA's debt to equity ratio has reduced from 50.8% to 31.3% over the past 5 years.

Debt Coverage: MEPA's debt is not well covered by operating cash flow (15.4%).

Interest Coverage: Insufficient data to determine if MEPA's interest payments on its debt are well covered by EBIT.


Balance Sheet


Dividend

What is Medical Packaging current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate MEPA's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate MEPA's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if MEPA's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if MEPA's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of MEPA's dividend in 3 years as they are not forecast to pay a notable one for the EG market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?


CEO

Mahir Syed

no data

Tenure

Dr. Mahir Moosa Syed serves as Managing Director of Medical Packaging Company.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Medical Packaging Company's employee growth, exchange listings and data sources


Key Information

  • Name: Medical Packaging Company
  • Ticker: MEPA
  • Exchange: CASE
  • Founded: 2006
  • Industry: Metal and Glass Containers
  • Sector: Materials
  • Market Cap: ج.م140.760m
  • Shares outstanding: 345.00m
  • Website: https://www.med-pack.com

Location

  • Medical Packaging Company
  • 124 Osman Abn Afan
  • Heliopolis
  • Cairo
  • Egypt

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/10/22 14:31
End of Day Share Price2021/10/20 00:00
Earnings2021/06/30
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.